JSRI 📈 BNP Paribas Easy MSCI - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1753045928 • Japan Large-Cap Equity
JSRI: Stocks, Bonds, Japanese, Equities
‣ Company URL: http://www.bnpparibas-am.com ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Japan TME NR JPY
Additional Sources for JSRI ETF
JSRI ETF Overview
| Market Cap in USD | 467m |
| Category | Japan Large-Cap Equity |
| TER | 0.26% |
| IPO / Inception | 2022-01-01 |
JSRI ETF Ratings
| Growth 5y | 12.9% |
| Fundamental | - |
| Dividend | 22.2% |
| Rel. Strength Industry | -76.9 |
| Analysts | - |
| Fair Price Momentum | 20.42 EUR |
| Fair Price DCF | - |
JSRI Dividends
| Dividend Yield 12m | 1.84% |
| Yield on Cost 5y | 1.99% |
| Annual Growth 5y | % |
| Payout Consistency | 100.0% |
JSRI Growth Ratios
| Growth Correlation 3m | 5.4% |
| Growth Correlation 12m | 7.3% |
| Growth Correlation 5y | 26.1% |
| CAGR 5y | 1.64% |
| CAGR/Mean DD 5y | 0.15 |
| Sharpe Ratio 12m | -0.08 |
| Alpha | -11.45 |
| Beta | 0.41 |
| Volatility | 13.75% |
| Current Volume | 34k |
| Average Volume 20d | 5.3k |
What is the price of JSRI stocks?
As of December 22, 2024, the stock is trading at EUR 21.79 with a total of 34,025 shares traded.
Over the past week, the price has changed by -3.29%, over one month by +2.21%, over three months by -0.87% and over the past year by +4.32%.
As of December 22, 2024, the stock is trading at EUR 21.79 with a total of 34,025 shares traded.
Over the past week, the price has changed by -3.29%, over one month by +2.21%, over three months by -0.87% and over the past year by +4.32%.
Is BNP Paribas Easy MSCI a good stock to buy?
Neither. Based on ValueRay Analyses, BNP Paribas Easy MSCI is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 12.91 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JSRI as of December 2024 is 20.42. This means that JSRI is currently overvalued and has a potential downside of -6.29%.
Neither. Based on ValueRay Analyses, BNP Paribas Easy MSCI is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 12.91 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JSRI as of December 2024 is 20.42. This means that JSRI is currently overvalued and has a potential downside of -6.29%.
Is JSRI a buy, sell or hold?
BNP Paribas Easy MSCI has no consensus analysts rating.
BNP Paribas Easy MSCI has no consensus analysts rating.
What are the forecast for JSRI stock price target?
According to ValueRays Forecast Model, JSRI BNP Paribas Easy MSCI will be worth about 22.3 in December 2025. The stock is currently trading at 21.79. This means that the stock has a potential upside of +2.25%.
According to ValueRays Forecast Model, JSRI BNP Paribas Easy MSCI will be worth about 22.3 in December 2025. The stock is currently trading at 21.79. This means that the stock has a potential upside of +2.25%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.3 | 2.2% |